financetom
Business
financetom
/
Business
/
RTX Raises Alarm Over Post-COVID Supply Chain Issues: Report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RTX Raises Alarm Over Post-COVID Supply Chain Issues: Report
Sep 11, 2024 10:27 AM

RTX Corporation ( RTX ) shares are trading lower on Wednesday. The company reportedly raised concerns about global supply chains post-COVID-19 at a key aerospace event.

The company highlighted the significant challenge of finding qualified labor for high-demand jet industry production lines, reported Reuters.

Also Read: ‘Not A Slam Dunk For Harris, But The Chances Of A Trump Victory Have Slipped:’ Investors, Markets Adjust Positions After Presidential Debate

The report quoted Executive Chairman Greg Hayes as saying, “We’re also trying to minimize the geopolitical risk by saying – OK, we’ve got 2,000 suppliers in China today. What happens if, and we don’t know what that if is – what happens if and how are we going to deal with that?”

“So we have been actively working again, not to pull suppliers or not to pull out of China, but to make sure that we have alternatives if we know something bad does happen.”

“Today, it’s still a huge challenge to find qualified folks to work on some of these products and that is I’m afraid not gotten better nearly as quickly as demand has recovered.”

Other aerospace executives also warned of persistent disruptions due to high demand and shortages in parts and labor at the event.

The head of France’s aerospace company, Safran, noted that the sector faces challenges from labor loss during the pandemic, raw material supply issues, and rising energy prices.

The report cited Safran CEO Olivier Andries, who said, “We are in a period where there has never been such a tension between very strong demand and a supply chain that has been under pressure and suffered many shocks,” and further added that he expected more of this in 2025.

As per the report, a Chinese invasion of Taiwan would likely lead to U.S. sanctions on China, significantly affecting U.S. companies. RTX, which has 14,000 suppliers globally, halted purchases from Russian suppliers following Russia’s invasion of Ukraine.

In August, RTX disclosed that it had developed an air-to-air missile that could give the U.S. an upper hand against China.

Investors can gain exposure to the stock via iShares U.S. Aerospace & Defense ETF ( ITA ) and First Trust Exchange-Traded Fund First Trust Indxx Aerospace & Defense ETF .

Price Action: RTX shares are down 1.82% at $118.11 at the last check Wednesday.

Read Next:

Ukraine Attacks Moscow In Its Largest Drone Offensive Since War Began

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fluence Energy Delivers First US-Made Energy Storage System
Fluence Energy Delivers First US-Made Energy Storage System
Sep 4, 2025
09:27 AM EDT, 09/04/2025 (MT Newswires) -- Fluence Energy ( FLNC ) said Thursday it delivered domestic content lithium-ion battery storage systems called Gridstack Pro. The company said the delivery represents the first shipment of battery storage systems that use US-made batteries, modules, thermal management systems, controls and enclosures. ...
Mega Matrix Files for Up to $2 Billion Mixed Shelf
Mega Matrix Files for Up to $2 Billion Mixed Shelf
Sep 4, 2025
09:27 AM EDT, 09/04/2025 (MT Newswires) -- Mega Matrix (MPU) filed Thursday a shelf registration statement with the US Securities and Exchange Commission for the potential sale of up to $2 billion of its securities. The filing covers class A ordinary shares, preferred shares, debt securities, warrants, units or a combination thereof. Mega Matrix said that the terms of a...
Bright Minds Says BMB-201 Outperforms Sumatriptan in Preclinical Vascular Headache Trial
Bright Minds Says BMB-201 Outperforms Sumatriptan in Preclinical Vascular Headache Trial
Sep 4, 2025
09:26 AM EDT, 09/04/2025 (MT Newswires) -- Bright Minds Biosciences ( DRUG ) said Thursday that preclinical results for its investigational drug BMB-201 in a rat model of vascular headache showed greater effect sizes than sumatriptan at several timepoints. The results showed statistically significant reductions in facial mechanical allodynia across both male and female cohorts at 1 and 2 hours...
Gap to offer beauty and personal care products this fall
Gap to offer beauty and personal care products this fall
Sep 4, 2025
Sept 4 (Reuters) - Gap said on Thursday it would expand into the beauty and personal care segment, including some sold under the Old Navy brand, this fall season. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved